	Successor						Predecessor
				Period from			Period from
	Twelve Months			August 1, 2017			April 1, 2017			Twelve Months
	Ended			through			through			Ended
(In thousands, except share and per share data)	December 31, 2018			December 31, 2017			July 31, 2017			March 31, 2017
Net loss available to common shareholders	$	(171,517	)		(39,266	)		(1,646,909	)		(660,118	)
Weighted average outstanding shares of common stock, basic (A)		26,589,883			21,539,143			47,121,330			47,071,066
Dilutive effect of options, warrants and restricted stock awards and units		—			—			—			—
Weighted average common stock and equivalents		26,589,883			21,539,143			47,121,330			47,071,066

Loss per share, basic (B)	$	(6.45	)		(1.82	)		(34.95	)		(14.02	)
Loss per share, diluted (C)	$	(6.45	)		(1.82	)		(34.95	)		(14.02	)
Additional information:
Incremental "in-the-money" options, warrants, and restricted stock awards and units outstanding at the end of the period (D)		5,282,574			7,869,553			—			1,233

(A)

Basic weighted average shares outstanding included 2,547 and 924,125 shares issuable upon the exercise of New Creditor Warrants held by U.S. citizens at December 31, 2018 (Successor) and December 31, 2017 (Successor).

(B)

We calculate “Loss per share, basic” by dividing “Net loss available to common shareholders” by “Weighted average outstanding share of common stock, basic”.

(C)

We calculate “Loss per share, diluted” by dividing “Net loss available to common shareholders” by “Weighted average common stock and equivalents”.

(D)

For the twelve months ended December 31, 2018 and period from August 1, 2017 through December 31, 2017, we also had 5,923,399 and 5,062,089 shares of “out-of- the-money” warrants outstanding at the end of the periods, respectively.